	Multiple sclerosis in Peru: National prevalence study using capture-recapture analysis. Mult Scler Relat Disord O GG, C AD, K PB, W AQ, M M, J I, E R, C CZ, M M, E S, Am SQ, J B, M RB, A C, Ml R. PMID: 34332455 [PubMed - as supplied by publisher]
	Cognitive recovery in people with relapsing/remitting multiple sclerosis: A randomized clinical trial on virtual reality-based neurorehabilitation. Clin Neurol Neurosurg Leonardi S, Maggio MG, Russo M, Bramanti A, Arcadi FA, Naro A, Calabrò RS, De Luca R. PMID: 34332269 [PubMed - as supplied by publisher]
	Effectiveness of equine-assisted therapies for improving health outcomes in people with multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord Suárez-Iglesias D, Bidaurrazaga-Letona I, Sanchez-Lastra MA, Gil SM, Ayán C. PMID: 34329873 [PubMed - as supplied by publisher]
	SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study. Mult Scler Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Brescia Morra V, Trojano M, Tedeschi G, Comi G, Battaglia MA, Patti F, Fragoso YD, Sen S, Siva A, Furlan R, Salvetti M. PMID: 34328824 [PubMed - as supplied by publisher]
	High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis. Mult Scler Rotstein D, Maxwell C, Tu K, Gatley J, Pequeno P, Kopp A, Marrie RA. PMID: 34328821 [PubMed - as supplied by publisher]
	Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients. Mult Scler Pitteri M, Magliozzi R, Nicholas R, Ziccardi S, Pisani AI, Pezzini F, Marastoni D, Calabrese M. PMID: 34328817 [PubMed - as supplied by publisher]
	Association study of promoter polymorphisms of interferon alpha and beta receptor subunit 1 (IFNAR1) gene and therapeutic response to interferon-beta in patients with multiple sclerosis. Mol Biol Rep Hajian S, Mazdeh M, Nouri F, Roshanaei G, Soleimani M. PMID: 34328599 [PubMed - as supplied by publisher]
	Incidence of multiple sclerosis in China: A nationwide hospital-based study. Lancet Reg Health West Pac Tian DC, Zhang C, Yuan M, Yang X, Gu H, Li Z, Wang Y, Shi FD. PMID: 34327341 [PubMed]
	Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study. Front Neurol Giedraitiene N, Drukteiniene E, Kizlaitiene R, Cimbalas A, Asoklis R, Kaubrys G. PMID: 34326806 [PubMed]
	Progress in the Application of Drugs for the Treatment of Multiple Sclerosis. Front Pharmacol Wei W, Ma D, Li L, Zhang L. PMID: 34326775 [PubMed]
	Migraine in multiple sclerosis and other chronic inflammatory diseases. Rev Neurol (Paris) Moisset X, Giraud P, Dallel R. PMID: 34325914 [PubMed - as supplied by publisher]
	Exercise training improves participation in persons with multiple sclerosis: A systematic review and meta-analysis. J Sport Health Sci Edwards T, Michelsen AS, Fakolade AO, Dalgas U, Pilutti LA. PMID: 34325022 [PubMed - as supplied by publisher]
	Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study. CNS Drugs Castelnovo G, Gerlach O, Freedman MS, Bergmann A, Sinay V, Castillo-Triviño T, Kong G, Koster T, Williams H, Gafson AR, Killestein J. PMID: 34322853 [PubMed - as supplied by publisher]
	Prediction of Multiple sclerosis disease using machine learning classifiers: a comparative study. J Prev Med Hyg Darvishi S, Hamidi O, Poorolajal J. PMID: 34322636 [PubMed - in process]
	Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti-SARS-CoV-2 Antibodies: An Observational Study. Neurol Neuroimmunol Neuroinflamm Bigaut K, Kremer L, Fabacher T, Lanotte L, Fleury MC, Collongues N, de Seze J. PMID: 34321333 [PubMed - in process]
	Music-based therapy in rehabilitation of people with multiple sclerosis: a systematic review of clinical trials. Arq Neuropsiquiatr Lopes J, Keppers II. PMID: 34320057 [PubMed - in process]
	The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review. CNS Drugs Biolato M, Bianco A, Lucchini M, Gasbarrini A, Mirabella M, Grieco A. PMID: 34319570 [PubMed - as supplied by publisher]
	Neurocognitive performance in relapsing-remitting multiple sclerosis patients is associated with metabolic abnormalities of the thalamus but not the hippocampus- GABA-edited 1H MRS study. Neurol Res Kantorová E, Hnilicová P, Bogner W, Grendár M, Grossmann J, Ková, He, Strasser B, , Zele, Kur. PMID: 34313578 [PubMed - as supplied by publisher]
	The nutritional status of relapsing-remitting multiple sclerosis (RRMS) patients compared to that of healthy people: a Turkish hospital-based study. Nutr Neurosci Atuk Kahraman T, Y, Yetkin MF, Mirza M. PMID: 34311682 [PubMed - as supplied by publisher]
	[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. Nervenarzt Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Stangel M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Hunter ZR, Kallmann B, Kleinschnitz C, Klotz L, Leussink V, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber MS, Weber F, Zettl UK, Ziemssen T, Zipp F, die Multiple Sklerose Therapie Konsensus Gruppe (MSTKG).. PMID: 34297142 [PubMed - as supplied by publisher]

Articles 1 - 20 / 32677

Page 1 of 1634



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy